H. Michael Yu

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913

M. Mehta, P. Wen, H. Shih, 2018, Neuro-oncology.

Phase II Study of a Temozolomide-Based Chemo-radiotherapy Regimen for High Risk Low-Grade Gliomas: Long-term Results of Radiation Therapy Oncology Group (RTOG) 0424.

M. Mehta, B. Fisher, D. D'Souza, 2020, International journal of radiation oncology, biology, physics.